文献速递临床试验与 GCP基础与转化研究

经肌肉腰方肌阻滞用于腹腔镜结直肠手术:双盲随机安慰剂对照试验方案

Transmuscular quadratus lumborum (TQL) block for laparoscopic colorectal surgery: study protocol for a double-blind, prospective randomized placebo-controlled trial.
PubMed 文献 · Trials · 2020-06-26

该试验为前瞻性、随机、双盲、安慰剂对照研究,计划纳入150例腹腔镜结直肠手术患者,比较双侧经肌肉腰方肌阻滞(TQL,0.375%罗哌卡因30ml/侧)联合吗啡PCIA与生理盐水TQL联合吗啡PCIA的镇痛效果。主要终点为术后24小时吗啡消耗量,次要终点包括疼痛评分、肠道功能恢复、恶心呕吐发生率、PACU停留时间等。

要点

  • TQL阻滞可能通过扩散至胸椎旁间隙覆盖T4-L1皮节并影响内脏痛传导。
  • 主要终点为术后24小时吗啡消耗量,用于评价TQL阻滞的镇痛效果。
  • 研究同时监测罗哌卡因血浆浓度及局麻药全身毒性(LAST)等不良事件。

核心结论

  • 试验假设TQL阻滞在腹腔镜结直肠手术术后镇痛方面优于单纯吗啡PCIA。
  • 研究旨在明确TQL阻滞是否提供更优的术后疼痛控制。

研究设计与样本

  • 前瞻性、随机、双盲、安慰剂对照临床试验,纳入150例腹腔镜结直肠手术患者。
  • 患者随机分为TQL组(n=75)和安慰剂组(n=75),分别接受双侧TQL阻滞(0.375%罗哌卡因30ml/侧或生理盐水30ml/侧)联合术后吗啡PCIA。
  • TQL阻滞在麻醉诱导前实施。

主要发现

  • 原文未报告试验结果,仅描述研究方案。

关键数值与推荐

  • 主要终点:术后第一个24小时吗啡消耗量。
  • 次要终点包括NRS疼痛评分、肠道功能恢复时间(首次排气及首次固体进食时间)、首次活动时间、术后24小时恶心呕吐发生率、PACU及住院时间、两个时间点(入PACU和出PACU)感觉阻滞范围、PCA泵患者请求的静脉吗啡剂量、静脉吗啡总剂量、补救镇痛药(氯胺酮、可乐定)需求及剂量、诱导后及出PACU时游离罗哌卡因血浆浓度、治疗期间不良事件发生率(尤其LAST迹象)。

临床怎么用

  • 若试验证实TQL阻滞有效,可为腹腔镜结直肠手术提供一种替代硬膜外镇痛的术后镇痛方案。
  • 需关注TQL阻滞后罗哌卡因血浆浓度及LAST风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thoracic epidural anesthesia is no longer considered the gold standard for perioperative analgesia in laparoscopic colorectal procedures. In the search for alternatives, the efficacy of the transverse abdominal plane (TAP) block and other abdominal wall blocks such as the transmuscular quadratus lumborum (TQL) block continues to be investigated for postoperative pain management. Most of the initial studies on TAP blocks reported positive effects; however, the amount of studies with negative outcomes is increasing, most probably due to the fact that the majority of abdominal wall blocks fail to mitigate visceral pain. The TQL block could prove attractive in the search for better postoperative pain relief after laparoscopic colorectal surgery. In several cadaveric studies of the TQL, a spread of dye into the thoracic paravertebral space, the intercostal spaces, and even the thoracic sympathetic trunk was reported. Given the advantage of possibly reaching the thoracic paravertebral space, the potential to reach nerves transmitting visceral pain, and the possible coverage of dermatomes T4-L1, we hypothesize that the TQL provides superior postoperative analgesia for laparoscopic colorectal surgery as compared to patient-controlled intravenous analgesia with morphine alone. METHODS AND DESIGN: In this prospective, randomized, double-blind controlled clinical trial, 150 patients undergoing laparoscopic colorectal surgery will be included. Patients will be randomly allocated to two different analgesic strategies: a bilateral TQL with 30 ml ropivacaine 0.375% each on both sides, administered before induction of anesthesia, plus postoperative patient-controlled intravenous analgesia with morphine (TQL group, n = 75), or a bilateral TQL block with 30 ml saline each on both sides plus postoperative patient-controlled intravenous analgesia with morphine (placebo group, n = 75). Our primary outcome parameter will be the morphine consumption during the first 24 h postsurgery. Secondary endpoints include pain intensity as assessed with the numerical rating scale (NRS) for pain, time to return of intestinal function (defined as the time to first flatus and the time to the first postoperative intake of solid food), time to first mobilization, the incidence of postoperative nausea and vomiting during the first 24 h, length of stay on the post anesthesia care unit (PACU) and in the hospital, the extent of sensory block at two time points (admission to and discharge from the PACU), the doses of morphine IV as requested by the patient from the PCA pump, the total dosage of morphine administered IV, the need for and dose of rescue analgesics (ketamine, clonidine), free plasma ropivacaine levels after induction and at discharge from the PACU, and the incidence of adverse events during treatment (in particular, signs of local anesthetic systemic toxicity (LAST)). Epidural analgesia is no longer the standard of care for postoperative analgesia in laparoscopic colorectal surgery. Until now, the most effective analgesic strategy in these patients especially in an enhanced recovery program is still unknown. Several abdominal wall blocks (TAP, fascia transversalis plane block) are known to have an analgesic effect only on somatic pain. Recognizing the importance of procedure-specific pain management, we aim to investigate whether a transmuscular quadratus lumborum block delivers superior pain control in comparison to patient-controlled intravenous analgesia with morphine alone. TRIAL REGISTRATION: EudraCT identifier 2019-002304-40. Registered on 17 September 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Coppens S, Rex S, Fieuws S, et al. Transmuscular quadratus lumborum (TQL) block for laparoscopic colorectal surgery: study protocol for a double-blind, prospective randomized placebo-controlled trial. Trials. 2020. PMID: 32586361. doi:10.1186/s13063-020-04525-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。